From MNKD IR
The meeting portal allows shareholders to log in using their control number (provided by your broker). Once logged in, there is an input box on the portal webpage that allows shareholders to submit written questions. On our end, we will see a running list of questions that have been submitted.
If they see the same questions asked they should be obligated to answer. A few I am submitting.
Where are we with Canada and Mexico?
What's the latest status on India trials?
Why aren't we working on approval in UK?
What is the opportunity for the CV 19 partnership & time line?
When will we see revenue from Brazil?
When do you expect to finsh peds trial and how will you market Afrezza to that patient group?
To join the call:
If you would like to attend the virtual meeting and you have your control number, please go to
www.virtualshareholdermeeting.com/MNKD2020 15 minutes prior to the start of the meeting to log in. If you came through your brokerage firm's website and do not have your control number, you can gain access to the meeting by logging into your brokerage firm's website 15 minutes prior to the meeting start, selecting the shareholder communications mailbox to link through to the meeting and the control number will automatically populate